GlaxoSmithKline Opens Cape Town Drug Plant Published: Nov 04, 2005 GlaxoSmithKline has opened a new $3 million facility in Cape Town, South Africa, that will produce medicine to treat the debilitating disease lymphatic filariasis. Related links Pharmaceutical Business Review This will open in a new window Email this Facebook Twitter LinkedIn Pinterest Reddit Back to news